| Gait variability in older adults: a structured review of testing protocol and clinimetric properties S Lord, T Howe, J Greenland, L Simpson, L Rochester Gait & posture 34 (4), 443-450, 2011 | 239 | 2011 |
| The clinical heterogeneity of Parkinson's disease and its therapeutic implications JC Greenland, CH Williams‐Gray, RA Barker European Journal of Neuroscience 49 (3), 328-338, 2019 | 228 | 2019 |
| Parkinson’s disease: pathogenesis and clinical aspects [internet] TB Stoker, JC Greenland Codon Publications, 2018 | 220 | 2018 |
| Parkinson’s Disease: Pathogenesis and Clinical Aspects A Kouli, KM Torsney, WL Kuan, TB Stoker, JC Greenland Brisbane (AU): Codon Publications, 3-26, 2018 | 145 | 2018 |
| Huntington’s disease: Diagnosis and management TB Stoker, SL Mason, JC Greenland, ST Holden, H Santini, RA Barker Practical Neurology 22 (1), 32-41, 2022 | 135 | 2022 |
| The differential diagnosis of Parkinson’s disease JC Greenland, RA Barker Exon Publications, 109-128, 2018 | 77 | 2018 |
| Codon Publications: Brisbane TB Stoker, JC Greenland Australia, 2018 | 51 | 2018 |
| Early constipation predicts faster dementia onset in Parkinson’s disease M Camacho, AD Macleod, J Maple-Grødem, JR Evans, DP Breen, ... npj Parkinson's Disease 7 (1), 1-7, 2021 | 48 | 2021 |
| Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol JC Greenland, E Cutting, S Kadyan, S Bond, A Chhabra, ... BMJ open 10 (11), e040527, 2020 | 38 | 2020 |
| The Gastrointestinal Dysfunction Scale for Parkinson's Disease M Camacho, JC Greenland, CH Williams‐Gray Movement Disorders 36 (10), 2358-2366, 2021 | 25 | 2021 |
| In Parkinson’s Disease: Pathogenesis and Clinical Aspects JC Greenland, RA Barker Codon Publications-Brisbane, QLD, 2018 | 18 | 2018 |
| Codon Publications: Brisbane, Australia, 2018 TB Stoker, JC Greenland | 18 | |
| Parkinson’s Disease: Pathogenesis and Clinical Aspects [Internet] EA Konnova, M Swanberg, TB Stoker, JC Greenland | 12 | 2018 |
| Natural killer cells have an activated profile in early Parkinson's disease J Holbrook, B Patel, M Camacho, L Kahanawita, J Greenland, ... Journal of Neuroimmunology, 578154, 2023 | 7 | 2023 |
| The dilemma between milestones of progression versus clinical scales in Parkinson's disease JC Greenland, M Camacho, CH Williams-Gray Handbook of Clinical Neurology 192, 169-185, 2023 | 5 | 2023 |
| 123 T and B lymphocyte senescence in parkinson’s disease M Jensen, K Scott, M Camacho, J Greenland, A Kouli, R Wijeyekoon, ... Journal of Neurology, Neurosurgery and Psychiatry 90 (12), e35, 2019 | 1 | 2019 |
| Clinical Trial Highlights: Anti-Inflammatory and Immunomodulatory Agents B Patel, JC Greenland, CH Williams-Gray Journal of Parkinson’s Disease 14 (7), 1283-1300, 2024 | | 2024 |
| Validation of a 5‐Year Prognostic Model for Parkinson's Disease J Ribeiro, M Camacho, KM Scott, JC Greenland, JR Evans, DP Breen, ... Movement Disorders Clinical Practice, 2024 | | 2024 |
| Investigating immunosuppression as a disease modifying strategy in Parkinson's disease J Greenland | | 2024 |
| Characterization of gastrointestinal dysfunction in Parkinson's by disease stage M Camacho, J Greenland, D Apostolopoulos, C Daruwalla, ... MOVEMENT DISORDERS 37, S620-S620, 2022 | | 2022 |
